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Objective
To discover a miRNA with diagnostic characteristics for
diffuse alveolar damage (DAD) in an animal of acute
lung injury (ALI) and in patients with the ARDS.
Methods
Male rats (325-372 gr) underwent mechanical ventila-
tion for 2.5 h with VT=9 ml/kg + PEEP=5 cm H2O (low
VT, LV, n=10); or VT=25 ml/kg + PEEP=0 cm H2O
(high VT, HV, n=19) (11 of 19 developed DAD at histo-
logical examination). Whole miRNA expression (RNA-
seq-Single Read, 72 cycles, Illumina GaIIx) was analyzed
in lung parenchyma. miRNA expression in LV vs. HV
and in HV-DAD vs. HV-no-DAD was compared. We
used a data mining strategy to prioritize the most rele-
vant miRNA within the miRNAs differentially expressed.
Prioritized miRNAs were validated in (1) serum from
the same group of rats (RT-PCR); (2) human lung tissue
(preserved at -80º after sampling) from autopsies of
patients with ARDS (RT-PCR and in situ hybridization)
(n=20); (3) human serum from mechanically ventilated
patients obtained during the first 24 hours of ICU
admission (n=66, 14 nonsurvivors). A p value < 0.05
was considered statistically significant. Results are med-
ian (IQR), and odds ratio (OR [95% confidence inter-
val]). RT-PCR results were expressed x10-4. Categorical
and continuous variables were compared with c2 and
Mann-Whitney, respectively. Predictive multivariate
logistic analysis was used to identify independent risk
factors. The area under ROC curve (AUROC, mean
±SEM) was used to assess the discriminatory capacity.
Multiple-comparison was adjusted by FDR. The local
Ethics Committee approved this study.
Results
19 miRNAs were differentially expressed in rat lungs
between the 3 groups, one of them (herein named
miRNA A) containing the information to classify animals
in the 3 groups (97% correct classification in the original
dataset, and 86% in 5 fold cross-validation analysis). In
rat serum, miRNA A expression differed in the 3 groups
(p=0.045) (AUROC for the presence of DAD 0.76 [0.521-
1.000], p=0.036 for the difference with the line of iden-
tity). miRNA expression in human serum was associated
with mortality. Variables in multivariate analyses for the
preediction of mortality were: SAPS II score (OR 1.05
[1.01-1.10], p=0.02), and miRNA A expression (OR 1.06
[1.01-1.12; p=0.04) (AUROC for the logistic model
0.84 [0.73-0.96]; for SAPSII 0.76 [0.60-0.92] and for
miRNA A 0.76 [0.63-0.89]). miRNA A was more
expressed in lung tissue from 39 patients with the diag-
nosis of ARDS than in patients without ARDS (p< 0.01).
In human lung parenchyma miRNA A was detected
(RT-PCR), localized in alveolar type II cells, macrophages
and interstitium (in situ hybridization).
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Conclusions
We have identified one miRNA associated with DAD in
an animal model of ALI, that is expressed in human
lung tissue, and whose expression in human serum cor-
relates with mortality and with the diagnosis of ARDS.
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